C12Y 302/02029
Thymine-dna glycosylase
Official title: Thymine-DNA glycosylase (3.2.2.29)
C12Y302/02029 (Thymine-dna glycosylase) appears on 4 US grants and 9 published applications in this corpus.
Search patents in C12Y- Granted patents
- 4
- Published applications
- 9
- Assignees
- 8
- Inventors
- 24
- Latest grant
- 10 Oct 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 1 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 2 | 1 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 1 | 1 |
| 2024 | 0 | 2 |
By publication year.
Recent patents
- Targeted DNA demethylation and methylation10 Oct 2023US 11,780,895 B2The Jackson Laboratory
- Lymphangiogenesis inhibitors for cancer and for graft survival12 Mar 2019US 10,226,509 B2Tufts University
- Combination of DNA repair inhibition with bendamustine or gemcitabine in the treatment of cancer5 Mar 2019US 10,220,051 B2Institute For Cancer Research
- Combination of DNA repair inhibition with bendamustine or gemcitabine in the treatment of cancer6 Jan 2015US 8,927,516 B2Institute For Cancer Research
- Methods of Library Preparation30 May 2024US 2024/0175010 A1Illumina, Inc.
- Targeted dna demethylation and methylation25 Apr 2024US 2024/0132557 A1The Jackson Laboratory
- Methods and compositions related to a hybrid dna repair glycosylase and a thermostable dna lyase23 Feb 2023US 2023/0059186 A1Board of Regents, The University of Texas System
- Detecting methylcytosine and its derivatives using s-adenosyl-l-methionine analogs (xsams)15 Sep 2022US 2022/0290234 A1Illumina Cambridge Limited
- Targeted dna demethylation and methylation5 Mar 2020US 2020/0071369 A1The Jackson Laboratory
Most cited
By later US patents